The Clorox Company (NYSE:CLX) Shares Acquired by Fisher Asset Management LLC

Fisher Asset Management LLC increased its stake in shares of The Clorox Company (NYSE:CLX) by 2.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 22,966 shares of the company’s stock after purchasing an additional 493 shares during the period. Fisher Asset Management LLC’s holdings in Clorox were worth $3,275,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Choreo LLC boosted its stake in shares of Clorox by 12.8% in the fourth quarter. Choreo LLC now owns 5,741 shares of the company’s stock worth $819,000 after acquiring an additional 652 shares during the last quarter. abrdn plc boosted its stake in Clorox by 20.1% during the 4th quarter. abrdn plc now owns 198,250 shares of the company’s stock worth $28,268,000 after purchasing an additional 33,135 shares during the last quarter. Savoir Faire Capital Management L.P. grew its holdings in shares of Clorox by 61.8% during the fourth quarter. Savoir Faire Capital Management L.P. now owns 65,192 shares of the company’s stock worth $9,296,000 after buying an additional 24,897 shares in the last quarter. International Assets Investment Management LLC raised its position in shares of Clorox by 17,658.5% in the fourth quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock valued at $69,078,000 after buying an additional 481,725 shares during the last quarter. Finally, Victory Capital Management Inc. lifted its stake in shares of Clorox by 3.9% in the fourth quarter. Victory Capital Management Inc. now owns 172,526 shares of the company’s stock worth $24,600,000 after buying an additional 6,510 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Performance

Shares of CLX stock opened at $135.69 on Friday. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $169.14. The firm has a 50 day moving average of $137.72 and a two-hundred day moving average of $144.05. The company has a quick ratio of 0.53, a current ratio of 0.90 and a debt-to-equity ratio of 9.73. The stock has a market capitalization of $16.85 billion, a PE ratio of 70.30, a P/E/G ratio of 2.25 and a beta of 0.39.

Clorox (NYSE:CLX) last released its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.33 by $0.38. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The firm had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same period in the prior year, the firm earned $1.51 earnings per share. The business’s quarterly revenue was down 5.3% compared to the same quarter last year. On average, research analysts predict that The Clorox Company will post 5.84 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. The Goldman Sachs Group initiated coverage on shares of Clorox in a report on Friday, March 1st. They issued a “sell” rating and a $140.00 price objective for the company. Citigroup lowered their price objective on Clorox from $155.00 to $150.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 1st. JPMorgan Chase & Co. cut their target price on Clorox from $159.00 to $158.00 and set a “neutral” rating for the company in a research note on Wednesday, May 1st. Wells Fargo & Company lowered their price target on shares of Clorox from $140.00 to $135.00 and set an “underweight” rating on the stock in a research report on Thursday, May 2nd. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on shares of Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a research report on Wednesday, April 17th. Four analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $146.43.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.